Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the CoronavirusOvertaxed healthcare systems will delay enrollment in some geographic locations - BioSpace

Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the CoronavirusOvertaxed healthcare systems will delay enrollment in some geographic locations  BioSpace

Comments

Popular posts from this blog

Could GLP-1 RAs Improve COVID-19-Induced Pulmonary Arterial Hypertension? - AJMC.com Managed Markets Network